Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Infectious bone diseases
MeSH D001850 - infectious bone diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001847:
Bone diseases
6 Companies
1 Drug
$
Success rate
D007239:
Infections
2 Companies
2 Drugs
$
Success rate
D001850:
Infectious bone diseases
85 Companies
26 Drugs
$
Success rate
D010019:
Osteomyelitis
46 Companies
10 Drugs
$
Success rate
D010522:
Periostitis
0 Companies
0 Drugs
Success rate
D013166:
Spondylitis
0 Companies
0 Drugs
Success rate
D014394:
Osteoarticular tuberculosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
19/19
Approved:
19
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Avibactam
,
Ceftazidime
Alcon Research
Tobramycin
Allergan
Prednisolone
,
Prednisolone tebutate
,
Tobramycin
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use